Stephane Bancel Moderna, Inc. (MRNA) insider trading activity

Stephane Bancel is Chief Executive Officer of Moderna, Inc.. Currently has a direct ownership of 5.49 Million shares of MRNA, which is worth approximately $380 Million. The most recent transaction as insider was on Oct 06, 2021, when has been sold 9,000 shares (Common Stock) at a price of $318.23 per share, resulting in proceeds of $2,864,070. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.49M

0% 3M change

1.05% 12M change

Total Value Held $380 Million

Stephane Bancel Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 06 2021	SELL Open market or private sale	$2,864,070 $318.23 p/Share	9,000 Reduced 0.15%	6,061,868 Common Stock
Sep 29 2021	SELL Bona fide gift	-	4,000 Reduced 0.07%	6,070,868 Common Stock
Sep 29 2021	SELL Open market or private sale	$3,540,960 $393.44 p/Share	9,000 Reduced 0.15%	6,074,868 Common Stock
Sep 22 2021	SELL Bona fide gift	-	4,000 Reduced 0.07%	6,083,868 Common Stock
Sep 22 2021	SELL Open market or private sale	$3,897,000 $433.0 p/Share	9,000 Reduced 0.15%	6,087,868 Common Stock
Sep 15 2021	SELL Bona fide gift	-	4,000 Reduced 0.07%	6,096,868 Common Stock
Sep 15 2021	SELL Open market or private sale	$3,844,170 $427.13 p/Share	9,000 Reduced 0.15%	6,100,868 Common Stock
Sep 08 2021	SELL Bona fide gift	-	4,000 Reduced 0.07%	6,109,868 Common Stock
Sep 08 2021	SELL Open market or private sale	$3,903,480 $433.72 p/Share	9,000 Reduced 0.15%	6,113,868 Common Stock
Sep 01 2021	SELL Bona fide gift	-	4,000 Reduced 0.07%	6,122,868 Common Stock
Sep 01 2021	SELL Open market or private sale	$3,436,380 $381.82 p/Share	9,000 Reduced 0.15%	6,126,868 Common Stock
Aug 25 2021	SELL Bona fide gift	-	4,000 Reduced 0.07%	6,135,868 Common Stock
Aug 25 2021	SELL Open market or private sale	$3,524,310 $391.59 p/Share	9,000 Reduced 0.15%	6,139,868 Common Stock
Aug 18 2021	SELL Bona fide gift	-	4,000 Reduced 0.07%	6,148,868 Common Stock
Aug 18 2021	SELL Open market or private sale	$3,663,000 $407.0 p/Share	9,000 Reduced 0.15%	6,152,868 Common Stock
Aug 11 2021	SELL Bona fide gift	-	4,000 Reduced 0.06%	6,161,868 Common Stock
Aug 11 2021	SELL Open market or private sale	$3,990,060 $443.34 p/Share	9,000 Reduced 0.15%	6,165,868 Common Stock
Aug 04 2021	SELL Bona fide gift	-	4,000 Reduced 0.06%	6,174,868 Common Stock
Aug 04 2021	SELL Open market or private sale	$3,463,650 $384.85 p/Share	9,000 Reduced 0.15%	6,178,868 Common Stock
Jul 28 2021	SELL Bona fide gift	-	4,000 Reduced 0.06%	6,187,868 Common Stock
Jul 28 2021	SELL Open market or private sale	$2,996,280 $332.92 p/Share	9,000 Reduced 0.15%	6,191,868 Common Stock
Jul 21 2021	SELL Bona fide gift	-	4,000 Reduced 0.06%	6,200,868 Common Stock
Jul 21 2021	SELL Open market or private sale	$2,691,000 $299.0 p/Share	9,000 Reduced 0.14%	6,204,868 Common Stock
Jul 14 2021	SELL Bona fide gift	-	2,000 Reduced 0.03%	6,213,868 Common Stock
Jul 14 2021	SELL Open market or private sale	$2,134,980 $237.22 p/Share	9,000 Reduced 0.14%	6,215,868 Common Stock

Stephane Bancel

Chief Executive Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Moderna, Inc.

Track Activities on MRNA

Account